Dario Barbone

1.1k total citations
20 papers, 862 citations indexed

About

Dario Barbone is a scholar working on Pulmonary and Respiratory Medicine, Biotechnology and Molecular Biology. According to data from OpenAlex, Dario Barbone has authored 20 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 10 papers in Biotechnology and 9 papers in Molecular Biology. Recurrent topics in Dario Barbone's work include Occupational and environmental lung diseases (16 papers), Cancer Research and Treatments (9 papers) and Cell death mechanisms and regulation (5 papers). Dario Barbone is often cited by papers focused on Occupational and environmental lung diseases (16 papers), Cancer Research and Treatments (9 papers) and Cell death mechanisms and regulation (5 papers). Dario Barbone collaborates with scholars based in United States, United Kingdom and Italy. Dario Barbone's co-authors include V. Courtney Broaddus, Giovanni Gaudino, Tsung‐Ming Yang, Luciano Mutti, Camillo Porta, Jeffrey R. Morgan, Dean A. Fennell, Raphael Bueno, Mitchell Ho and Yen Phung and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Dario Barbone

20 papers receiving 853 citations

Peers

Dario Barbone
Susan E. Alters United States
Jonathan F. Anker United States
Ahmad Jalili Austria
Philip Levy Ho United States
Arno Amann Austria
Dario Barbone
Citations per year, relative to Dario Barbone Dario Barbone (= 1×) peers Haiping Jiang

Countries citing papers authored by Dario Barbone

Since Specialization
Citations

This map shows the geographic impact of Dario Barbone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dario Barbone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dario Barbone more than expected).

Fields of papers citing papers by Dario Barbone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dario Barbone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dario Barbone. The network helps show where Dario Barbone may publish in the future.

Co-authorship network of co-authors of Dario Barbone

This figure shows the co-authorship network connecting the top 25 collaborators of Dario Barbone. A scholar is included among the top collaborators of Dario Barbone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dario Barbone. Dario Barbone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Follo, Carlo, Dario Barbone, William G. Richards, Raphael Bueno, & V. Courtney Broaddus. (2019). Autophagy in 3D In Vitro and Ex Vivo Cancer Models. Methods in molecular biology. 1880. 491–510. 1 indexed citations
2.
Barbone, Dario, Carlo Follo, Puthen V. Jithesh, et al.. (2016). Analysis of Gene Expression in 3D Spheroids Highlights a Survival Role for ASS1 in Mesothelioma. PLoS ONE. 11(3). e0150044–e0150044. 33 indexed citations
3.
Follo, Carlo, Dario Barbone, William G. Richards, Raphael Bueno, & V. Courtney Broaddus. (2016). Autophagy initiation correlates with the autophagic flux in 3D models of mesothelioma and with patient outcome. Autophagy. 12(7). 1180–1194. 16 indexed citations
4.
Barbone, Dario, Carlo Follo, N Echeverry, et al.. (2015). Autophagy Correlates with the Therapeutic Responsiveness of Malignant Pleural Mesothelioma in 3D Models. PLoS ONE. 10(8). e0134825–e0134825. 12 indexed citations
5.
Echeverry, N, Dario Barbone, Walter Weder, et al.. (2015). Inhibition of autophagy sensitizes malignant pleural mesothelioma cells to dual PI3K/mTOR inhibitors. Cell Death and Disease. 6(5). e1757–e1757. 42 indexed citations
6.
Busacca, Sara, Astero Klabatsa, Ken Arthur, et al.. (2013). Correction: BAK and NOXA Are Critical Determinants of Mitochondrial Apoptosis Induced by Bortezomib in Mesothelioma. PLoS ONE. 8(12). 1 indexed citations
7.
Barbone, Dario, Priscilla Cheung, Sara Busacca, et al.. (2012). Vorinostat Eliminates Multicellular Resistance of Mesothelioma 3D Spheroids via Restoration of Noxa Expression. PLoS ONE. 7(12). e52753–e52753. 29 indexed citations
8.
Hurwitz, Jane, Emma Kerr, Caitriona Holohan, et al.. (2011). Vorinostat/SAHA-induced apoptosis in malignant mesothelioma is FLIP/caspase 8-dependent and HR23B-independent. European Journal of Cancer. 48(7). 1096–1107. 36 indexed citations
9.
Phung, Yen, Dario Barbone, V. Courtney Broaddus, & Mitchell Ho. (2011). Rapid Generation of In Vitro Multicellular Spheroids for the Study of Monoclonal Antibody Therapy. Journal of Cancer. 2. 507–514. 65 indexed citations
10.
Barbone, Dario, Jeremy Ryan, Nikita Kolhatkar, et al.. (2011). The Bcl-2 repertoire of mesothelioma spheroids underlies acquired apoptotic multicellular resistance. Cell Death and Disease. 2(6). e174–e174. 41 indexed citations
11.
Aceto, Nicola, Pietro Bertino, Dario Barbone, et al.. (2009). Taurolidine and oxidative stress: a rationale for local treatment of mesothelioma. European Respiratory Journal. 34(6). 1399–1407. 22 indexed citations
12.
Bidlingmaier, Scott, Jiang He, Yong Wang, et al.. (2009). Identification of MCAM/CD146 as the Target Antigen of a Human Monoclonal Antibody that Recognizes Both Epithelioid and Sarcomatoid Types of Mesothelioma. Cancer Research. 69(4). 1570–1577. 65 indexed citations
13.
Barbone, Dario, Tsung‐Ming Yang, Jeffrey R. Morgan, Giovanni Gaudino, & V. Courtney Broaddus. (2008). Mammalian Target of Rapamycin Contributes to the Acquired Apoptotic Resistance of Human Mesothelioma Multicellular Spheroids. Journal of Biological Chemistry. 283(19). 13021–13030. 122 indexed citations
14.
Wilson, Shannon M., Dario Barbone, Tsung‐Ming Yang, et al.. (2008). mTOR Mediates Survival Signals in Malignant Mesothelioma Grown as Tumor Fragment Spheroids. American Journal of Respiratory Cell and Molecular Biology. 39(5). 576–583. 47 indexed citations
15.
Yang, Tsung‐Ming, Dario Barbone, Dean A. Fennell, & V. Courtney Broaddus. (2008). Bcl-2 Family Proteins Contribute to Apoptotic Resistance in Lung Cancer Multicellular Spheroids. American Journal of Respiratory Cell and Molecular Biology. 41(1). 14–23. 60 indexed citations
16.
Bertino, Pietro, Anna Maria Marconi, Dario Barbone, et al.. (2007). Erionite and asbestos differently cause transformation of human mesothelial cells. International Journal of Cancer. 121(1). 12–20. 37 indexed citations
17.
Bertino, Pietro, Camillo Porta, Dario Barbone, et al.. (2007). Preliminary data suggestive of a novel translational approach to mesothelioma treatment: imatinib mesylate with gemcitabine or pemetrexed. Thorax. 62(8). 690–695. 45 indexed citations
18.
Sartore‐Bianchi, Andrea, Fabio Gasparri, Arturo Galvani, et al.. (2007). Bortezomib Inhibits Nuclear Factor-κB–Dependent Survival and Has Potent In vivo Activity in Mesothelioma. Clinical Cancer Research. 13(19). 5942–5951. 84 indexed citations
19.
Barbone, Dario, Ki‐Up Kim, Claire Vivo, et al.. (2007). Malignant mesothelioma cells are rapidly sensitized to TRAIL-induced apoptosis by low-dose anisomycin via Bim. Molecular Cancer Therapeutics. 6(10). 2766–2776. 32 indexed citations
20.
Barbone, Dario, Camillo Porta, Deborah A. Altomare, et al.. (2005). SV40-Dependent AKT Activity Drives Mesothelial Cell Transformation after Asbestos Exposure. Cancer Research. 65(12). 5256–5262. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026